Study guide
3.1 Endogenous Enzyme Blocking
ASCP Qualification in Immunohistochemistry QIHC
Track your progress as you read
Finished sections get a check mark.
1 Introduction and Exam Overview
1.1 Current QIHC Exam Facts 1.2 Eligibility, CMP, and How to Use This Guide
2 Detection Systems: Immunofluorescence, Enzymes, and Chromogens
2.1 Immunofluorescence Detection 2.2 Detection Enzymes 2.3 Chromogens and Substrates 2.4 Dual-Chromogen and Multiplex Detection
3 Detection Systems: Blocking, Polymer, and Amplification
3.1 Endogenous Enzyme Blocking 3.2 Biotin and Protein Blocking 3.3 Polymer and Multimer Detection 3.4 Amplification Systems
4 Specimen Handling: Fixation, Processing, and Microtomy
4.1 Fixation for IHC 4.2 Tissue Processing 4.3 Microtomy and Slide Preparation
5 Specimen Handling: Cytology, Immunofluorescence, and Frozen Sections
5.1 Cytology Specimens for IHC 5.2 Immunofluorescence Specimens 5.3 Frozen Sections
6 Epitope Enhancement and Antigen Retrieval
6.1 HIER Chemistry and Buffer Systems 6.2 HIER Equipment and Protocols 6.3 Enzyme-Induced Epitope Retrieval 6.4 Combined Retrieval and Optimization
7 Staining Principles and General Immunology
7.1 Antibodies: Structure, Classes, Monoclonal versus Polyclonal 7.2 Antigens and Epitopes 7.3 Direct and Indirect Methods 7.4 Avidin-Biotin Methods
8 Polymer Methods, In Situ Hybridization, and Staining Reagents
8.1 Polymer and Multimer Staining Methods 8.2 In Situ Hybridization (FISH, CISH, SISH) 8.3 Antibody Formats and Titration 8.4 Diluents and Staining Reagents
9 Tissues: Morphology, Cytokeratins, Organ Markers, and Microorganisms
9.1 Morphology, Anatomy, and Basic Pathology 9.2 Cytokeratin Profiling and CUP Patterns 9.3 Organ-Specific Epithelial Markers 9.4 Infectious IHC and Microorganisms
10 Lineage Markers and Preliminary Screening
10.1 Hematolymphoid Markers 10.2 Melanoma, Mesenchymal, and Neuroendocrine Markers 10.3 Preliminary Screening and Expected Patterns
11 Staining Troubleshooting and Mounting
11.1 Staining Troubleshooting 11.2 Mounting Procedures
12 Quality Control, Controls, and Analytic Validation
12.1 Documentation, Lots, Slide Storage, and Personnel 12.2 Control Tissue Selection and Use 12.3 Method Selection, Optimization, and CAP Analytic Validation 12.4 Operational Troubleshooting
13 Safety, Laboratory Mathematics, Equipment, and Regulations
13.1 Laboratory Safety 13.2 Laboratory Mathematics 13.3 Ancillary Equipment and Automated Stainers 13.4 Regulations: Federal Government and Accrediting Agencies
3.1 Endogenous Enzyme Blocking
Key Takeaways Explain This Topic AI
Hydrogen peroxide inactivates tissue peroxidase-like activity before HRP chromogen; aqueous 3% H2O2 is the usual FFPE vehicle, while methanol-H2O2 is chosen when intracellular red-cell heme is still highly active
Place the peroxidase block after the last step that can uncover enzyme (often after HIER on automated stainers) and rinse thoroughly so leftover peroxide does not kill detection HRP
Levamisole in the AP substrate inhibits most non-intestinal tissue alkaline phosphatase; it is expected on frozen and cytology AP runs and is often unnecessary on fully processed FFPE
Over-blocking (high-percent peroxide, long incubations, no rinse) weakens true signal; under-blocking leaves RBC and granulocyte DAB traps that appear even on omit-primary controls
Last updated: September 2026
Endogenous reporter-like enzymes are already in the tissue. Detection systems then add horseradish peroxidase (HRP) or alkaline phosphatase (AP) as the intended catalyst. If you apply chromogen without first silencing the tissue enzymes, red cells, granulocytes, and some epithelia deposit the same color as a true antibody-enzyme reaction. That false deposit is not overstaining of antigen. It is enzyme activity that never needed an antibody.
This section stays inside detection-system chemistry: how hydrogen peroxide and levamisole remove those tissue enzymes, when the block sits relative to epitope retrieval, why frozen and formalin-fixed paraffin-embedded (FFPE) slides do not behave the same, and how an overly aggressive block can weaken the very HRP or AP you just applied. Biotin-free polymer detection does not replace these enzyme blocks. Polymer removes avidin-biotin chemistry; it does not remove heme or tissue AP.
Why the block exists
HRP detection with DAB or AEC reads any peroxidase-like activity. Human tissues contain catalase, cytochromes, and hemoglobin. Hemoglobin in erythrocytes has pseudoperoxidase activity: it reduces peroxide and oxidizes DAB to a brown polymer that looks like cytoplasmic immunoreactivity if morphology is ignored. Neutrophils, eosinophils, and some macrophages carry true myeloperoxidase. A bloody marrow clot, hemorrhagic tumor, spleen, or granulation-tissue biopsy can therefore stain brown even on the negative reagent control.
AP detection with Fast Red, Permanent Red, or BCIP/NBT reads tissue alkaline phosphatase. Small-intestinal brush border, proximal renal tubules, placenta, osteoblasts, regenerating bile ductules, and neutrophils are the usual sources. FFPE processing and heat-induced epitope retrieval (HIER) destroy much of this activity. Frozen sections, smears, and some lightly fixed cytology preparations keep it.
The clinical job is selective inactivation: stop tissue enzyme, leave the detection enzyme you will add later, and leave the epitope intact.
Hydrogen peroxide for HRP: aqueous versus methanol
Hydrogen peroxide inactivates peroxidase by oxidizing the heme catalytic center. Typical working strength is about 3% H2O2 in water or buffer for 5–10 minutes on FFPE, or a more dilute 0.3% H2O2 in methanol for 10–30 minutes when methanol is the vehicle. Neither number is a universal standard; the laboratory's validated protocol owns time and concentration. What you must be able to explain is the vehicle.
Aqueous hydrogen peroxide (3% in distilled water, PBS, or TBS) is the default on most FFPE polymer-HRP runs. It does not add a second organic fixative. Membrane antigens that are unhappy in methanol—some leukocyte CD markers, some glycoprotein epitopes—are safer in aqueous peroxide. The tradeoff is penetration: intact red-cell membranes and densely packed heme can be incompletely quenched, so residual erythrocyte DAB remains, especially in clots and spleen.
Methanol-hydrogen peroxide combines solvent and oxidizer. Methanol permeabilizes membranes, denatures some proteins, and helps peroxide reach intracellular heme. That is why it is classically chosen for frozen sections and for bloody specimens in which erythrocyte ghosts dominate the field. The tradeoff is epitope risk: methanol can reduce labeling of some surface antigens and can harden tissue before retrieval. Methanol-peroxide after a delicate HIER step can also lift sections as the slide dries.
- Vehicle Typical use Strength Main risk
- Aqueous 3% H2O2 Routine FFPE polymer-HRP Milder on membrane epitopes Incomplete RBC quench
Methanol 0.3–3% H2O2 Frozen tissue; heavy hemorrhage Better intracellular heme access Methanol-sensitive antigens; section loss
No peroxide block Almost never for HRP-DAB on bloody tissue Saves a step RBC and granulocyte DAB traps
A polymer system does not replace peroxide block. Polymer is biotin-free; it is not peroxidase-free. Tissue peroxidase still oxidizes DAB whether the secondary reagent is ABC-HRP or a micropolymer-HRP.
When to block relative to retrieval
Epitope retrieval and peroxide block both change the section. Order is part of the validated method, not a personal preference at the bench.
Block after retrieval is common on automated stainers. HIER opens the meshwork of fixed protein so peroxide reaches residual heme. Heat has already reduced much enzyme activity, but erythrocytes still show pseudoperoxidase. Applying 3% aqueous H2O2 after retrieval, rinsing, then applying primary antibody is the pattern many clinical polymer protocols use. Conceptually, the peroxidase block should sit after the last step that could restore or uncover enzyme and before HRP-conjugated detection reagent .
Block before retrieval remains common in manual recipes: dewax, rehydrate, apply methanol-H2O2, then retrieve. Methanol is easier to control on a rehydrated slide than on a loosely adhered retrieved section. If you place methanol-peroxide after high-temperature retrieval, sections detach. Aqueous peroxide before HIER is also used; heat then continues to denature enzyme.
Do not treat retrieval as a substitute block. HIER reduces AP and peroxidase but does not reliably silence red-cell pseudoperoxidase. Enzyme-induced epitope retrieval (EIER) with trypsin, pepsin, or proteinase K likewise does not replace H2O2.
Rinse as part of the block. Leftover peroxide is a dissolved inhibitor of the detection HRP you apply later. A beautiful quench of red cells followed by a weak true signal is often residual H2O2, not low antigen.
Levamisole for alkaline phosphatase
Levamisole (L-tetramisole) is a competitive inhibitor of most non-intestinal tissue AP isoforms. It is added to the chromogen-substrate working solution (commonly in the low millimolar range per kit insert), not as a separate slide pretreatment analogous to H2O2. It does nothing useful in an HRP-DAB run and must not be used as a substitute for peroxide.
Intestinal AP is relatively levamisole-resistant. Small-bowel mucosa can still show brush-border chromogen with AP-red detection even when levamisole is present. In that setting the fix is method choice (HRP instead of AP), not more levamisole.
FFPE plus HIER inactivates most endogenous AP, so many paraffin polymer-AP kits omit levamisole. Frozen sections, unfixed smears, and some cytology preparations require it if AP is the reporter. Historical strong-acid pretreatments also destroy AP but damage morphology and epitopes; levamisole in the substrate is the practical control.
Frozen versus FFPE
- Feature FFPE Frozen / lightly fixed
- Endogenous peroxidase Reduced by formalin and heat; RBC ghosts still trap DAB High intact activity
- Endogenous AP Usually low after processing and HIER Often strong in gut, kidney, placenta, neutrophils
Typical HRP block 3% aqueous H2O2, 5–10 min, often after retrieval Methanol-H2O2 or aqueous with extra attention to heme
- Levamisole in AP substrate Often omitted Expected
- Over-block pattern Residual peroxide weakens polymer-HRP Methanol plus long peroxide weakens labile antigens
Frozen IHC is not the same protocol without the processor. Enzyme blocks are part of why frozen and FFPE validation are separate.
Over-blocking that weakens true signal
More peroxide is not more specificity.
High concentration (jumping from 3% to 10–30%) or very long incubations oxidize amino acids in epitopes (methionine, cysteine, tryptophan) and can flatten true labeling.
Failure to rinse leaves H2O2 in the buffer film; polymer-HRP or ABC-HRP is inactivated on contact.
Sodium azide in some antibody diluents inhibits HRP; that is a reagent-inhibition trap related to the same enzyme, not a tissue block.
Stacking methanol-peroxide, harsh HIER, and a concentrated polymer on a scant biopsy can yield pale specific stain and clean red cells—technically no background and diagnostically useless.
The RBC and granulocyte trap is the opposite error: under-blocking . Intact erythrocytes and neutrophils deposit DAB. Readers call it nonspecific cytoplasmic staining in a vascular tumor or positive blasts in a crushed marrow. Morphology (biconcave ghosts, granular myeloid cytoplasm) and a negative reagent control that is equally brown in the same cells give the diagnosis of endogenous peroxidase, not antigen.
In practice
A hemorrhagic glioblastoma stained with polymer-HRP/DAB shows brown red cells in the clot and clean tumor-cell nuclei for a nuclear marker. That is expected residual pseudoperoxidase, not failed antibody. If the same slide's nuclear marker is weak and red cells are stark brown after a 30-minute 10% aqueous block with a poor rinse, over-blocking plus residual peroxide is the better hypothesis. Return to a short 3% aqueous step after retrieval, rinse, and re-run before retitrating the primary.
For AP-red on a frozen small-bowel biopsy, levamisole will not erase brush-border AP. Choose HRP detection or interpret the brush border as endogenous enzyme. For a bone-marrow clot, plan on RBC pseudoperoxidase from the start: aqueous peroxide after retrieval, complete rinses, and morphology before you call cytoplasmic DAB in erythroid islands a blast marker.